Innovative Alzheimer Prevention Research at IFN 2021: Richard Isaacson, MD
September 2nd 2021The director of the Alzheimer’s Prevention Clinic at Weill Cornell Medicine discussed the topics and ideas that clinicians should look forward to at the 2021 International Congress on the Future of Neurology.
COVID-19’s Potential Effect on Dementia Risk: James E. Galvin, MD, MPH
September 1st 2021The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine discussed the current understanding of COVID-19 and its associations with cognitive decline and Alzheimer disease.
New AASM Guideline for Treatment of Central Disorders of Hypersomnolence: Lynn Marie Trotti, MD
August 31st 2021The associate professor of neurology at Emory University School of Medicine provided an overview of the new guideline, which addresses narcolepsy, idiopathic hypersomnia, and Kleine-Levin syndrome.
Dementia Research in Multicultural Communities: James E. Galvin, MD, MPH
August 30th 2021The director of the Comprehensive Center for Brain Health at the University of Miami Miller School of Medicine discussed projects dedicated towards improving dementia recognition and care within multicultural communities.
Importance of Headache Research for Transgender and Gender-Diverse Patients
August 29th 2021Jennifer Hranilovich, MD, assistant professor of pediatrics and neurology at the University of Colorado School of Medicine, discussed a recent narrative review that evaluated research on headache in transgender and gender-diverse patients.
The Status of NMOSD Patient Education and the Development Pipeline
August 28th 2021Bruce Cree, MD, PhD, clinical research director of the UCSF Multiple Sclerosis Center, provided context on the status of patient education efforts and clinical development for neuromyelitis optica spectrum disorder.